Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase II study by the Polish Adult Leukemia Group (PALG)

Annals of Hematology

Volumn 85, Issue 10, 2006, Pages 717-722

  Giebel, Sebastian ^a   Krawezy Kulis, Malgorzata ^a   Adamezyk Cioch, M Maria ^a,b   Jakubas, B Beata ^c   Palynyezko, G Grazyna ^d   Lewandowski, Krysztof ^e   Dmoszynska, Anna ^b   Skotnicki, Aleksander ^c   Nowak, Katarzyna ^a   Holowiecki, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Lublin Medical Academy   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^e POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Acute lymphoblastic leukemia; Fludarabine cytarabine mitoxantrone; Refractory; Relapsed

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINASE; BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASIA; ARTICLE; BACTERIAL INFECTION; BLEEDING; BRAIN METASTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DEATH; DIARRHEA; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; INCIDENCE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LIVER METASTASIS; LIVER TOXICITY; LONG TERM CARE; LUNG TOXICITY; LYMPH NODE METASTASIS; MALE; MEDIASTINUM METASTASIS; MORTALITY; MUCOSA INFLAMMATION; MULTICENTER STUDY; MYCOSIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PAIN; PHASE 2 CLINICAL TRIAL; POLAND; PRIORITY JOURNAL; PROBABILITY; SEPSIS; SPLEEN DISEASE; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; MITOXANTRONE; POLAND; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; SEPSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 33747411243     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0121-5     Document Type: Article

References (25)

1. Avivi I, Rowe JM (2003) Acute lymphocytic leukemia: Role of hematopoietic stem cell transplantation in current management. Curr Opin Hematol 10:463-468
2. Bassan R, Lerede T, Barbui T (1996) Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults. Haematologica 81:20-36
3. Camera A, Annino L, Chiurazzi F, Fazi P, Cascavilla N, Fabbiano F, Marmont F, Di Raimondo F, Recchia A, Vignetti M, Rotoli B, Mandelli F (2004) GIMEMA ALL - Rescue 97: A salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia. Haematologica 89:145-153
4. Gandhi V, Estey E, Keating MJ, Plunkett W (1993) Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J Clin Oncol 11:116-124
5. Giona F, Testi AM, Annino L, Amadori S, Arcese W, Camera A, Di Montezemolo LC, Ladogana S, Liso V, Meloni G et al (1994) Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: The GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologia ed Ocologia Pediatrica. Br J Haematol 86:55-61
6. Gokbuget N, Hoelzer D (2003) Treatment with monoclonal antibodies in acute lymphoblastic leukemia: Current knowledge and future prospects. Ann Hematol 83:201-205
7. Grigg AP, Szer J, Beresford J, Dodds A, Bradstock K, Durrant S, Schwarer AP, Hughes T, Herrmann R, Gibson J, Arthur C, Matthews J (1999) Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia. Br J Haematol 107:409-418
8. Hoelzer D, Goekbuget N (2002) Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol 6:114-141
9. Holowiecki J, Giebel S, Krzemien S, Krawczyk-Kulis M, Jagoda K, Kopera M, Holowiecka B, Grosicki S, Hellmann A, Dmoszynska A, Paluszewska M, Robak T, Konopka L, Maj S, Wojnar J, Wojciechowska M, Skotnicki A, Baran W, Cioch M (2002) G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: A randomized multicenter study. Leuk Lymphoma 43:315-325
10. Kern W, Schleyer E, Braess J, Wittmer E, Ohnesorge J, Unterhalt M, Wormann B, Buchner T, Hiddemann W (2001) Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias. Ann Hematol 80:334-339
11. Koller CA, Kantarjian HM, Thomas D, O'Brien S, Rios MB, Kornblau S, Murphy S, Keating M (1997) The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia 11:2039-2044
12. Martino R, Bellido M, Brunet S, Altes A, Sureda A, Guardia R, Aventin A, Nomdedeu JF, Domingo-Albos A, Sierra J (1999) Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: Results of a prospective trial. Haematologica 84:505-510
13. Martino R, Bellido M, Brunet S, Sureda A, Peyret M, Guardia R, Altes A, Domingo-Albos A, Sierra J (1998) Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia. Bone Marrow Transplant 21:1023-1027
14. Michelutti A, Michieli M, Damiani D, Melli C, Ermacora A, Grimaz S, Candoni A, Russo D, Fanin R, Baccarani M (1997) Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. Haematologica 82:143-147
15. Montillo M, Tedeschi A, Centurioni R, Leoni P (1997) Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leuk Lymphoma 25:579-583
16. Ottmann OG, Wassmann B (2005) Treatment of philadelphia chromosome - positive acute lymphoblastic leukemia. Hematology (American Society of Hematology Education Book), pp 118-122
17. Robak T, Korycka A, Kasznicki M, Wrzesien-Kus A, Smolewski P (2005) Purine nucleoside analogues for the treatment of hematological malignancies: Pharmacology and clinical applications. Curr Cancer Drug Targets 5:421-444
18. Rosen PJ, Rankin C, Head DR, Boldt DH, Luthardt FW, Norwood T, Pugh RP, Karanes C, Appelbaum FR (2000) A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. Leuk Res 24:183-187
19. Specchia G, Pastore D, Carluccio P, Liso A, Mestice A, Rizzi R, Ciuffreda L, Pietrantuono G, Liso V (2005) FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia. Ann Hematol 84:792-795
20. Styczynski J, Wysocki M, Debski R, Czyzewski K, Balwierz W, Juraszewska E, Matysiak M, Malinowska I, Stanczak E, Sonta-Jakimczyk D, Szczepanski T, Wachowiak J, Konatkowska B, Balcerska A, Ploszynska A, Kowalczyk J, Stefaniak J, Badowska W, Wieczorek M, Olejnik I, Krawczuk-Rybak M, Kuzmicz M (2005) In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: Good activity in leukemic relapses. Neoplasma 52:74-78
21. Teachey DT, Obzut DA, Cooperman J, Fang J, Carroll M, Choi JK, Houghton PJ, Brown VI, Grupp SA (2006) The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL. Blood 107:1149-1155
22. Thomas DA, Kantarjian H, Smith TL, Koller C, Cortes J, O'Brien S, Giles FJ, Gajewski J, Pierce S, Keating MJ (1999) Primary refractory and relapsed adult acute lymphoblastic leukemia: Characteristics, treatment results, and prognosis with salvage therapy. Cancer 86:1216-1230
23. Visani G, Tosi P, Zinzani PL, Manfroi S, Ottaviani E, Cenacchi A, Carrara P, Clavio M, Gobbi M, Tura S (1996) FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: In vitro and in vivo effects. Eur J Haematol 56:308-312
24. Weiss M, Maslak P, Feldman E, Berman E, Bertino J, Gee T, Megherian L, Seiter K, Scheinberg D, Golde D (1996) Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. J Clin Oncol 14:2480-2485
25. Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-271